Literature DB >> 31636164

Eosinophilic myocarditis presenting with hypoactive delirium and cardioembolic stroke.

Ka Hong Chan1, Paul Gibson2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31636164      PMCID: PMC6805170          DOI: 10.1503/cmaj.190669

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Guideline for the investigation and management of eosinophilia.

Authors:  Nauman M Butt; Jonathan Lambert; Sahra Ali; Philip A Beer; Nicholas C P Cross; Andrew Duncombe; Joanne Ewing; Claire N Harrison; Steven Knapper; Donal McLornan; Adam J Mead; Deepti Radia; Barbara J Bain
Journal:  Br J Haematol       Date:  2017-01-23       Impact factor: 6.998

Review 2.  Eosinophilic Myocarditis.

Authors:  Christopher C Cheung; Maggie Constantine; Amir Ahmadi; Carolyn Shiau; Luke Y C Chen
Journal:  Am J Med Sci       Date:  2017-04-06       Impact factor: 2.378

Review 3.  Drug-induced eosinophilia.

Authors:  Christine Rauscher; Allison Freeman
Journal:  Allergy Asthma Proc       Date:  2018-05-01       Impact factor: 2.587

4.  Eosinophilic Myocarditis: Characteristics, Treatment, and Outcomes.

Authors:  Michela Brambatti; Maria Vittoria Matassini; Eric D Adler; Karin Klingel; Paolo G Camici; Enrico Ammirati
Journal:  J Am Coll Cardiol       Date:  2017-11-07       Impact factor: 24.094

Review 5.  Eosinophilia.

Authors:  Anna Kovalszki; Peter F Weller
Journal:  Prim Care       Date:  2016-10-14       Impact factor: 2.907

Review 6.  Hypereosinophilic syndrome: cardiac diagnosis and management.

Authors:  Rekha Mankad; Crystal Bonnichsen; Sunil Mankad
Journal:  Heart       Date:  2015-11-13       Impact factor: 5.994

Review 7.  Cardiovascular manifestations of hypereosinophilic syndromes.

Authors:  Princess U Ogbogu; Douglas R Rosing; McDonald K Horne
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

Review 8.  World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.

Authors:  Jason Gotlib
Journal:  Am J Hematol       Date:  2017-11       Impact factor: 10.047

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.